New hope for pulmonary fibrosis: Researchers at the Heidelberg site of the German Center for Lung Research (DZL) have developed an immunotherapy-based approach that selectively eliminates senescent fibroblasts and could promote lung regeneration. The findings...
How is artificial intelligence transforming pulmonary research? At the DZL DataLung Symposium 2026, researchers, clinicians, and data scientists gathered at Schloss Rauischholzhausen to discuss innovative AI approaches, data-driven research, and interdisciplinary collaboration.
International experts in clinical, translational, and basic science research gathered in Giessen, Germany, from May 6–8, 2026, for the eurILDreg Symposium “Re-shaping eurILDreg: structure, organisation, research goals” to discuss current developments and future strategies in...
During the 64th Annual Meeting of the German Society of Nuclear Medicine (DGN), Prof. Uwe Haberkorn was awarded the Georg von Hevesy Medal. With this distinction, the DGN recognizes outstanding scientific achievements that have made...
A recent study at the DZL partner site BREATH shows that the protein S100A8 plays a crucial role in the lung’s immune defense against bacterial pneumonia. The findings open up new perspectives for diagnostic and...
A research team, with participation from the DZL, has developed an innovative human “lung-on-a-chip” model that realistically replicates key mechanisms of ventilator-associated pneumonia (VAP).
A recent scientific statement from the American Heart Association, published in the journal Circulation, places greater emphasis on right ventricular function in both research and clinical care for pulmonary hypertension (PH).
A newly developed nanobody could significantly expand treatment options for cystic fibrosis. For the first time, researchers have succeeded in engineering a cell-permeable antibody fragment that acts directly inside cells and stabilises the CFTR channel,...
A recent study published in the Journal of Controlled Release explores innovative strategies to deliver RNA-based therapies directly to the lungs. The findings provide important impulses for the development of new treatment approaches for inflammatory...
A recent study involving researchers from the DZL shows that increased airway resistance may serve as an early indicator of future lung damage, even in seemingly healthy smokers. The findings were published in the American...
Despite major advances in research, many cases of bronchiectasis remain idiopathic. DZL researchers are now investigating whether subtle CFTR dysfunction may play an underappreciated role.
A recent study published in the European Respiratory Journal provides important new insights into the early identification and monitoring of chronic obstructive pulmonary disease (COPD). The focus is on airway wall thickness as an imaging...
